Your browser doesn't support javascript.
loading
[89Zr]Zr-DFO-girentuximab and [18F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma.
Verhoeff, Sarah R; Oosting, Sjoukje F; Elias, Sjoerd G; van Es, Suzanne C; Gerritse, Sophie L; Angus, Lindsay; Heskamp, Sandra; Desar, Ingrid M E; Menke-van der Houven van Oordt, C Willemien; van der Veldt, Astrid A M; Arens, Anne I J; Brouwers, Adrienne H; Eisses, Bertha; Mulders, Peter F A; Hoekstra, Otto S; Zwezerijnen, Gerben J C; van der Graaf, Winette T A; Aarntzen, Erik H J G; Oyen, Wim J G; van Herpen, Carla M L.
Afiliación
  • Verhoeff SR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Oosting SF; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • van Es SC; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Gerritse SL; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Angus L; Department of Medical Oncology, Amsterdam UMC location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Heskamp S; Departments of Medical Oncology and Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Desar IME; Department of Radiology, Nuclear Medicine and Anatomy, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Menke-van der Houven van Oordt CW; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van der Veldt AAM; Department of Medical Oncology, Amsterdam UMC location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Arens AIJ; Departments of Medical Oncology and Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Brouwers AH; Department of Radiology, Nuclear Medicine and Anatomy, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Eisses B; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Mulders PFA; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Hoekstra OS; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Zwezerijnen GJC; Department of Radiology and Nuclear Medicine, Amsterdam UMC location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • van der Graaf WTA; Department of Radiology and Nuclear Medicine, Amsterdam UMC location VUMC, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Aarntzen EHJG; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Oyen WJG; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Herpen CML; Department of Radiology, Nuclear Medicine and Anatomy, Radboud University Medical Center, Nijmegen, the Netherlands.
Clin Cancer Res ; 29(3): 592-601, 2023 02 01.
Article en En | MEDLINE | ID: mdl-36394882

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos